Close
Smartlab Europe
Achema middle east

News

Peli BioThermal Expands Role for Dominic Hyde to Include Global Services

Peli BioThermal, the global name in temperature controlled packaging solutions,announces Dominic Hyde in his new role as Vice President of Global Services. In this role, Hyde will expand his responsibilities to all global services, including the worldwide service network...

Cryoport Expands Global Supply Chain Network with Belgium Acquisition

Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences including clinical research, pharmaceutical and cell and gene therapy markets, announced the expansion of its global supply chain network with the acquisition of...

Syntegon presents numerous innovations at ACHEMA Pulse

Ever smaller batches for individual therapeutic approaches, new cost-intensive biopharmaceuticals, and the Covid-19 pandemic are currently changing the pharmaceutical industry more rapidly than ever before. Syntegon Technology showcases solutions to these challenges at the virtual ACHEMA Pulse from June...

Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced that it has agreed to make a controlling investment in Mirus Bio, an innovator and developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery...

The U.S. plans to send 20 million vaccination doses to help world battle the virus

President Biden, heeding widespread calls to step up his response to the pandemic’s surge abroad, said on Monday that his administration would send 20 million doses of federally authorized coronavirus vaccine overseas in June — the first time he...

BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain To Support Ongoing Strong Growth of Pre-Filled Drug Delivery Business

BD (Becton, Dickinson and Company), a leading global medical technology company, will build a €165 million ($200 million USD) high-tech manufacturing facility in city of Zaragoza, located in the Aragon region of Spain, that will create up to 600...

Natco Pharma signs voluntary licensing agreement with Lilly for baricitinib for Covid-19 in India

Natco Pharma Limited announced the signing of a royalty-free, non-exclusive, voluntary licensing agreement with Eli Lilly and Company, for the manufacture and commercialization of the drug baricitinib for Covid-19 indication in India. In line with the licensing agreement, Natco has...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »